| The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases D Neavin, D Liu, B Ray, R Weinshilboum International Journal of Molecular Sciences 19 (12), 3851, 2018 | 208 | 2018 |
| DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine J Yu, B Qin, AM Moyer, S Nowsheen, T Liu, S Qin, Y Zhuang, D Liu, ... The Journal of clinical investigation 128 (6), 2376-2388, 2018 | 165 | 2018 |
| TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics M Gupta, D Neavin, D Liu, J Biernacka, D Hall-Flavin, WV Bobo, MA Frye, ... Molecular psychiatry 21 (12), 1717–1725., 2016 | 106 | 2016 |
| Functional characterization of five CYP2C8 variants and prediction of CYP2C8 genotype-dependent effects on in vitro and in vivo drug–drug interactions Y Gao, D Liu, H Wang, J Zhu, C Chen Xenobiotica 40 (7), 467-475, 2010 | 79 | 2010 |
| Beta-defensin 1, aryl hydrocarbon receptor and plasma kynurenine in major depressive disorder: metabolomics-informed genomics D Liu, B Ray, DR Neavin, J Zhang, AP Athreya, JM Biernacka, WV Bobo, ... Translational psychiatry 8 (1), 10, 2018 | 68 | 2018 |
| Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients S Bhattacharyya, AT Ahmed, M Arnold, D Liu, C Luo, H Zhu, ... Translational Psychiatry 9 (1), 173, 2019 | 63 | 2019 |
| Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression S MahmoudianDehkordi, AT Ahmed, S Bhattacharyya, X Han, RA Baillie, ... Translational psychiatry 11 (1), 153, 2021 | 50 | 2021 |
| Effects of CYP2C9* 3 and CYP2C9* 13 on diclofenac metabolism and inhibition-based drug-drug interactions J Zi, D Liu, P Ma, H Huang, J Zhu, D Wei, J Yang, C Chen Drug metabolism and pharmacokinetics 25 (4), 343-350, 2010 | 50 | 2010 |
| CYP2C9 and CYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense Variants L Zhang, V Sarangi, I Moon, J Yu, D Liu, S Devarajan, JM Reid, KR Kalari, ... Clinical and translational science 13 (4), 727-742, 2020 | 39 | 2020 |
| Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes AT Ahmed, S MahmoudianDehkordi, S Bhattacharyya, M Arnold, D Liu, ... Journal of Affective Disorders 264, 90-97, 2020 | 39 | 2020 |
| Evaluation of the effects of 20 nonsynonymous single nucleotide polymorphisms of CYP2C19 on S-mephenytoin 4′-hydroxylation and omeprazole 5′-hydroxylation H Wang, N An, H Wang, Y Gao, D Liu, T Bian, J Zhu, C Chen Drug Metabolism and Disposition 39 (5), 830-837, 2011 | 39 | 2011 |
| TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration‐Resistant Prostate Cancer S Qin, D Liu, M Kohli, L Wang, PT Vedell, DW Hillman, N Niu, J Yu, ... Clinical Pharmacology & Therapeutics 104 (1), 201-210, 2018 | 38 | 2018 |
| Association analysis of CYP2A6 genotypes and haplotypes with 5-fluorouracil formation from tegafur in human liver microsomes H Wang, T Bian, D Liu, T Jin, Y Chen, A Lin, C Chen Pharmacogenomics 12 (4), 481-492, 2011 | 32 | 2011 |
| Metabolism of tanshinol borneol ester in rat and human liver microsomes D Liu, X Zheng, Y Tang, J Zi, Y Nan, S Wang, C Xiao, J Zhu, C Chen Drug Metabolism and Disposition 38 (9), 1464-1470, 2010 | 31 | 2010 |
| Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication JB Joyce, CW Grant, D Liu, S MahmoudianDehkordi, R Kaddurah-Daouk, ... Translational psychiatry 11 (1), 513, 2021 | 26 | 2021 |
| ERICH3: vesicular association and antidepressant treatment response D Liu, Y Zhuang, L Zhang, H Gao, D Neavin, T Carrillo-Roa, Y Wang, J Yu, ... Molecular psychiatry 26 (6), 2415-2428, 2021 | 26 | 2021 |
| Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in HMMR as Biomarker for Chemotherapy- Induced Neutropenia in Breast Cancer … B Bidadi, D Liu, KR Kalari, M Rubner, A Hein, MW Beckmann, B Rack, ... Frontiers in Pharmacology 9, 158, 2018 | 24 | 2018 |
| Selective serotonin reuptake inhibitor pharmaco-omics: mechanisms and prediction TTL Nguyen, D Liu, MF Ho, AP Athreya, R Weinshilboum Frontiers in Pharmacology 11, 614048, 2021 | 18 | 2021 |
| Single Nucleotide Polymorphisms at a Distance from Aryl Hydrocarbon Receptor (AHR) Binding Sites Influence AHR Ligand–Dependent Gene Expression DR Neavin, JH Lee, D Liu, Z Ye, H Li, L Wang, T Ordog, ... Drug Metabolism and Disposition 47 (9), 983-994, 2019 | 17 | 2019 |
| TCF7L2 lncRNA: a link between bipolar disorder and body mass index through glucocorticoid signaling D Liu, TTL Nguyen, H Gao, H Huang, DC Kim, B Sharp, Z Ye, JH Lee, ... Molecular psychiatry 26 (12), 7454-7464, 2021 | 16 | 2021 |
Drew R NeavinResearch Officer, Garvan Institute of Medical ResearchVerified email at garvan.org.au
